Results 31 to 40 of about 117,571 (283)

LncRNAs expression in preeclampsia placenta reveals the potential role of LncRNAs contributing to preeclampsia pathogenesis. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Long non-coding RNAs (lncRNAs) are an important class of pervasive genes involved in a variety of biological functions. They are aberrantly expressed in many types of diseases.
Xiaoju He   +13 more
doaj   +1 more source

Prevalence rate and risk factors for preeclampsia and eclampsia among pregnant women attending Qena University Hospital During COVID-19 pandemic

open access: yesSVU - International Journal of Medical Sciences, 2023
Background: Preeclampsia and eclampsia are vital causes of maternal morbidity and mortality around the world. In Egypt, it complicates about 6%-8% of all pregnancies and can reach up to 15% in referral centers like university hospitals.
Rania Abd El Hakeem Ameen   +2 more
doaj   +1 more source

Genome-wide association study reveals HSF2, GJA1 and TRIM36 as susceptibility genes for preeclampsia: a community-based population study in Tianjin, China

open access: yesHypertension in Pregnancy, 2023
Background Preeclampsia (PE) mainly occurs in pregnant women and is hereditary. Several genome-wide association studies (GWAS) on Caucasian samples have reported some gene loci that are associated with preeclampsia.
Zhenhua Cao   +9 more
doaj   +1 more source

Neutrophil count is a useful marker to predict the severity of preeclampsia

open access: yesClinical and Experimental Hypertension, 2022
Background At present, pre-eclampsia is a growing concern and still a diagnostic challenge for obstetricians. Aims This study aimed to evaluate whether the relationship of second trimester of pregnancy neutrophil count differed among pregnancies with ...
Miao Liu   +13 more
doaj   +1 more source

Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study. [PDF]

open access: yesPLoS ONE, 2017
OBJECTIVES:Preeclampsia is divided into early-onset (delivery before 34 weeks of gestation) and late-onset (delivery at or after 34 weeks) subtypes, which may rise from different etiopathogenic backgrounds.
Pia M Villa   +11 more
doaj   +1 more source

Preeclampsia

open access: yesRevista Colombiana de Obstetricia y Ginecología, 1969
Las distintas manifestaciones de la toxicosis gravídica que precede a la máxi­ma complicación de ella, conocida con el nombre de eclampsia se ha denominado Preeclampsia. Este término comprende el conocido cuadro de las albuminurias gravidicas. primer eslabón de la cadena tóxica y la entidad de que nos ocupamos, conocida con el nombre Eclampsismo de ...
Rafael Peralta   +2 more
openaire   +3 more sources

Pregestational maternal risk factors for preterm and term preeclampsia: A population‐based cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2023
Introduction Most studies on factors affecting the risk of preeclampsia have not separated preterm from term preeclampsia, and we still know little about whether the predisposing conditions have a differentiated effect on the risk of preterm and term ...
Anne Kvie Sande   +4 more
doaj   +1 more source

Advancing hypertensive disorders of pregnancy management: insights from the 5th preeclampsia scientific symposium in Ghana

open access: yesBMC Proceedings
The 5th Preeclampsia Scientific Symposium (PSS2023) organized by Action on Preeclampsia (APEC) Ghana was themed: ‘Realign, Refocus: Improving outcomes of Hypertensive Disorders of Pregnancy through Shared Decision Making, Research & Quality of Care’.
Koiwah Koi-Larbi   +6 more
doaj   +1 more source

Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker.

open access: yesPLoS ONE, 2013
Preeclampsia is a placental disease characterized by hypertension and proteinuria in pregnant women, and it is associated with a high maternal and neonatal morbidity.
Julien Textoris   +7 more
doaj   +1 more source

Targeting the ARRDC3–DRP1 Axis via hUMSC‐Derived Exosomal CRYAB for Neuroprotection in Cerebral Ischemia/Reperfusion Injury

open access: yesAdvanced Healthcare Materials, EarlyView.
Intranasally administered hUMSC‐derived exosomes modulate the CRYAB–ARRDC3–Drp1 axis, alleviating mitochondrial dysfunction and ferroptosis, enhancing neuronal survival, reducing oxidative stress, and promoting functional recovery in ischemia‐reperfusion injury, offering a promising therapeutic strategy for ischemic stroke.
Rong ji   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy